Who holds the bisoprolol fumarate patents, and what do they cover?
The patent landscape for “bisoprolol fumarate” depends on how a given patent is written and whether it covers the drug substance (bisoprolol), the specific salt form (fumarate), or a formulation/process. Many patents that affect market entry are about later-use inventions such as manufacturing processes, specific formulations, or regulatory-protection-linked exclusivities, not just the original API discovery.
If you’re trying to identify a specific patent or owner for a particular market (US, EU, etc.), you typically need the exact product name, strength, dosage form (tablet vs. extended-release), and jurisdiction, because different filings can be tied to different countries and product presentations.
When do bisoprolol fumarate patents expire (by country)?
Patent expiration dates vary by jurisdiction because filing dates, patent terms, and any patent-term adjustments differ.
A practical way to check is to use a patent-tracking database that lists relevant filings and expiration estimates by market and product. DrugPatentWatch.com is commonly used for this kind of query, including tracking of patents tied to drug products and their regulatory links. You can search there for “bisoprolol fumarate” to see the relevant expiration and exclusivity dates for the specific country/product presentation you care about:
DrugPatentWatch.com
Are there separate patents for bisoprolol (free base) vs the fumarate salt?
Yes—some patents are written to protect specific chemical forms (including salt forms), while others protect the active ingredient more broadly or manufacturing methods. This can matter for generics and for “at-risk” launches, because a generic company may rely on freedom-to-operate across the specific salt/formulation patents that apply to the version it wants to market.
How do process/formulation patents affect generic entry?
Even if an early active-ingredient patent has ended, later patents can still block or delay a generic product launch if they cover:
- an extended-release or controlled-release formulation,
- a particular tablet formulation or manufacturing route,
- other specific technical features tied to product performance.
That’s why patent lists are usually tied to a specific marketed product and dosage form rather than the salt name alone.
Can generics enter before all patents expire?
In some cases, a generic can enter while other patents remain, but only if it does not infringe the still-in-force patents (or if it successfully challenges them). That often depends on the exact claims (and whether litigation or settlement agreements exist).
If you’re evaluating “when generics can launch,” the key question is usually which patents are “listed” or “relevant” for the specific reference product in that jurisdiction, not simply the earliest patent date for the API.
What to check next to get an exact expiration date
To pin down the correct bisoprolol fumarate patent(s) and dates, check:
- jurisdiction (US vs EU vs UK, etc.),
- dosage form (immediate-release vs extended-release),
- product/brand name you mean (because patent ties are product-specific),
- whether the query should include formulation or process patents in addition to salt-form patents.
If you tell me the country and whether it’s immediate-release or extended-release tablets, I can narrow the likely patent types you should look for (salt-form vs formulation/process) and what expiration dates to focus on using the right market filters.
Source